drug
as of 2026-07-01SIPI6398 Tablets
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Shanghai Zhongze Therapeutics Co., Ltd.
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
A Positron Emission Tomography (PET) Study to Evaluate Dopamine D2 and D3 Receptor Occupancy by SIPI6398
NCT07626034Phase 1, Phase 2Not Yet Recruiting
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication